Footprint with customer proximitySix cGMP-certified sites on three continents1
Helping patients across multiple health indicationsRevenue from across therapeutic areas with pharma and biotech customers
Solutions for development and commercial products“Start here – stay here”
1Data based on headcount as at 31 December 2022.
2Approximate splits as per 31 December 2022.
3Subsequent to the reporting period, one phase III project related to the treatment of cancer was terminated by the customer.
Business modelProviding expert knowledge for peptide- and oligonucleotide-based APIs along the entire life cycle
API – Active Pharmaceutical Ingredient; CMC – Chemistry, Manufacturing & Controls; cGMP – current Good Manufacturing Practice; ICH – International Council for Harmonization; LCM – Life Cycle Management; NDA – New Drug Application; PPQ – Process Performance Qualification.
Integrated strategyStriving to be the preferred long-term partner for customers